ChemImpex Rubitecan; 96% (HPLC); 91421-42-0; MFCD06656294, 25MG

Rubitecan is a potent chemical compound recognized for its unique structure and significant applications in the pharmaceutical industry, particularly in cancer treatment. This compound, also known as 9-Nitrocamptothecin, is a derivative of camptothecin and exhibits remarkable antitumor activity by inhibiting topoisomerase I, an enzyme crucial for DNA replication. Researchers and pharmaceutical developers leverage Rubitecans properties to explore innovative therapies for various cancers, including colorectal and lung cancer, making it a valuable asset in oncology research and drug formulation.

In addition to its therapeutic potential, Rubitecans unique chemical structure allows for modifications that can enhance its efficacy and reduce side effects, positioning it as a promising candidate for further development in targeted cancer therapies. Its ability to penetrate cellular membranes and selectively target cancer cells underscores its relevance in the ongoing quest for more effective cancer treatments. As researchers continue to investigate its full potential, Rubitecan stands out as a compound with significant promise in advancing cancer therapeutics.

Specifications

Safety & Regulations